Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Aug 04, 2021	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-21-000040.pdf 0001708138-21-000040.xls
Jul 07, 2021	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-21-000036.pdf 0001708138-21-000036.xls
Jul 02, 2021	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-21-000034.pdf 0001708138-21-000034.xls
Jul 02, 2021	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-21-000033.pdf 0001708138-21-000033.xls
Jul 02, 2021	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-21-000032.pdf 0001708138-21-000032.xls
Jun 28, 2021	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-21-000028.pdf 0001708138-21-000028.xls
Jun 23, 2021	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-21-000026.pdf 0001708138-21-000026.xls
Jun 16, 2021	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-21-000023.pdf 0001708138-21-000023.xls
Jun 16, 2021	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-21-000024.pdf 0001708138-21-000024.xls
Jun 16, 2021	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-21-082035.pdf 0001104659-21-082035.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Data provided by Kaleidoscope.

Investors & Media